Alliance Pharma

(APH)
Sector: Pharmaceuticals & Biotechnology
45.50p
0.00p 0.00
Last updated: 10:33:43

Share information

Name Alliance Pharma
Epic APH
Isin GB0031030819
Index AIM100 AIM350
Industry Pharmaceuticals & Biotechnology

Key numbers

Latest share price 45.50p Net gearing n/a
Market capitalisation £245.96 Debt ratio n/a
Shares in issue 540.40 Debt-to-equity ratio n/a
P/E ratio 12.4 Assets / equity ratio n/a
Total dividends per share 1.776p Price to book value n/a
Dividend yield 3.4 ROCE 16.17
Dividend cover 2.41 EPS growth -33
Earning per share 0.17 52-week high / low 29.35p / 47.70p

Dividends

Type Ex-date Pay-date Net-dividend
Final 2023-06-22 2023-07-18 1.184p
Interim 2022-12-22 2023-01-19 0.592p
Final 2022-06-09 2022-07-07 1.128p
Interim 2021-12-16 2022-01-07 0.563p
Final 2021-06-10 2021-07-08 1.074p
Interim 2020-12-17 2021-01-07 0.536p
Interim 2019-12-19 2020-01-10 0.536p
Final 2019-06-13 2019-07-11 0.977p
Interim 2018-12-20 2019-01-10 0.487p

Contact details

Company name Alliance Pharma
Address Avonbridge House, Bath Road, Chippenham, Wiltshire, United Kingdom, SN15 2BB
Telephone +44 (0)1249 466966
Website http://www.alliancepharma.co.uk

Directors

Director Position
Mr Peter Butterfield CEO
Mr Andrew Franklin CFO
Mr Camillo Pane Chairman
Mr Eva-Lotta Sjöstedt Non-Executive Director
Mr Richard McKenzie Non-Executive Director
Mr Richard Jones Senior Independent Director
Mr Kristof Neirynck Independent Non-Executive Director
Mr Martin Sutherland Independent Non-Executive Director
Mr Jeyan Heper Chief Operating Officer

Company financials

Assets £ (m) 2022 2021 2020
Reporting date 31/12/22 31/12/21 31/12/20
Intangible asssets and goodwill 421.63 413.74 412.87
Investments and other non-current assets n/a n/a n/a
Total non-current assets 431.93 422.47 431.61
Inventory / work in progress 24.29 21.07 22.92
Trade and other receivables 49.32 30.82 25.11
Cash and equivalents 31.71 29.06 28.9
Other current assets and asset held for resale 0.16 0.06 0.31
Total of all assets 537.41 503.49 508.85
Liabilities £ (m) 2022 2021 2020
Short term liabilities 47.02 40.58 30.19
Long term liabilities 202.73 180.42 197.71
Other liabilites / pension etc n/a n/a n/a
Total of all liabilities 249.75 221 227.9
Net assets £ (m) 2022 2021 2020
Net assets 287.66 282.49 280.96
Equity £ (m) 2022 2021 2020
Share capital 5.4 5.38 5.33
Minority interests n/a n/a n/a
Retained earnings 108.24 116.42 117.7
Share premium account 151.65 151.33 150.65
Total equity 287.66 282.49 280.96
Income £ (m) 2022 2021 2020
Turnover n/a n/a n/a
Operating profit 10.57 21.57 16.32
Pre-tax profit 5.21 18.16 13.02